Although IHC evaluation of the ATF6 and ATF6B in lung cancer tissues vs. case-matched non-cancerous tissues is somewhat inconclusive, the overall survival analysis for the lung cancer patients unraveled an opposite prognostic value between ATF6 and ATF6B. The gene discussed is ATF6B; the disease is lung cancer.